KRMD Form 4: 41,000-share disposition, 5.83M shares still held

KORU Medical Systems, Inc. (KRMD) reported an insider ownership update on a Form 4 filed by multiple reporting persons identified as a director and 10% owner.

Rhea-AI Filing Summary

KORU Medical Systems, Inc. (KRMD) reported an insider ownership update on a Form 4 filed by multiple reporting persons identified as a director and 10% owner. On 11/26/2025, a transaction coded "J(1)" involved the disposition of 41,000 shares of common stock at a stated price of $0. Following this transaction, the filer reports 5,830,335 shares of common stock beneficially owned indirectly through Horton Capital Partners Fund, LP, and an additional 517,200 shares of common stock beneficially owned directly. The filing includes customary disclaimers that it should not be construed as an admission of beneficial ownership or of any filing obligation.

Insider Trade Summary

Other: 41,000 shares

Other 2 txns

Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.

Role Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner

Type	Security	Shares	Price	Value
Other	Common Stock	41,000	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 5,830,335 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 517,200 shares (Direct)

Footnotes (2)

1. F1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. F2. See Exhibit 99.1 to this Form 4 for explanation of note (2).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the KRMD Form 4 filed on 11/26/2025 report?

It reported an insider ownership update for KORU Medical Systems, Inc. involving a transaction on 11/26/2025 and updated beneficial holdings in the company’s common stock.

How many KRMD shares were involved in the reported transaction?

The Form 4 shows a disposition of 41,000 shares of KORU Medical Systems common stock in a transaction coded "J(1)" at a stated price of $0.

What is the insider’s indirect ownership in KRMD after the transaction?

After the reported transaction, the filer reports indirect beneficial ownership of 5,830,335 shares of KORU Medical Systems common stock through Horton Capital Partners Fund, LP.

What is the insider’s direct ownership in KRMD after the transaction?

The filing also shows 517,200 shares of KORU Medical Systems common stock beneficially owned directly following the reported transaction.

What is the relationship of the reporting person to KORU Medical Systems (KRMD)?

The reporting person is identified as both a Director and a 10% Owner of KORU Medical Systems, Inc.

Does the KRMD Form 4 admit beneficial ownership of all reported shares?

No. The filing states that it should not be construed as an admission that the filer is the beneficial owner of any equity securities covered, or that the statement is legally required.

Is the KRMD Form 4 filed by a single or multiple reporting persons?

The form indicates it is filed by more than one reporting person, with signatures referencing Horton Capital-related entities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/26/2025 - 04:10 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Manko Joseph M. Jr.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		J(1)		41,000	D	$0	5,830,335	I	By Horton Capital Partners Fund, LP(2)
Common Stock								517,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Manko Joseph M. Jr.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Management, LLC

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Partners, LLC

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Partners Fund, L.P.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. See Exhibit 99.1 to this Form 4 for explanation of note (1).

2. See Exhibit 99.1 to this Form 4 for explanation of note (2).

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

	/s/ Joseph M. Manko, Jr.	11/26/2025
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC	11/26/2025
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC	11/26/2025
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.